Shopping Cart
Remove All
Your shopping cart is currently empty
Alsevalimab (FPA-150) is a humanized monoclonal antibody targeting B7-H4 with potential anti-tumor activity, used in the study of solid tumors.
| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 1 mg | $169 | - | In Stock | |
| 5 mg | $448 | - | In Stock | |
| 10 mg | $715 | - | In Stock | |
| 25 mg | $1,080 | - | In Stock | |
| 50 mg | $1,460 | - | In Stock |
| Description | Alsevalimab (FPA-150) is a humanized monoclonal antibody targeting B7-H4 with potential anti-tumor activity, used in the study of solid tumors. |
| Synonyms | FPA-150, FPA150, Anti-B7-H4 antibody |
| Reactivity | Human |
| Verified Activity | Immobilized Human B7-H4 Protein (ECD, His) at 2 μg/mL (30 μL/well) can bind Alsevalimab. The EC50 is 0.008484 μg/mL. |
| Application | Functional assay |
| Antibody Type | Monoclonal |
| Endotoxin | <1.0 EU/mg |
| Conjucates | Unconjugated |
| Gene ID | |
| Uniprot ID | |
| Target | B7-H4/VTCN1 |
| Molecular Weight | 144.78 kDa |
| Cas No. | 2254029-91-7 |
| Isotype | Human IgG1 kappa |
| Recommended Isotype Control |
| Storage | store at low temperature | -20°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.